UMMS researcher Victor Ambros, Ph.D., named co-recipient of 2012 Janssen Award for Biomedica... (rstand its full significance. We now kno...)

UMMS researcher Victor Ambros, Ph.D., named co-recipient of 2012 Janssen Award for Biomedical Research

Date:6/19/2012

rstand its full significance. We now know that microRNAs have key functions in a variety of human diseases, ranging from hyperlipidemia (high blood cholesterol) to cancer," said Terence R. Flotte, MD, executive deputy chancellor, provost, and dean of the School of Medicine.

Since the discovery of microRNAs in 1993, these regulatory molecules have been implicated in a wide range of both normal and pathological activities including embryonic development, blood-cell specialization, muscle function, heart disease and viral infections. Their discovery has opened new fields of research and has implications for the development of new therapeutic treatments and diagnostic tools.

Working independently, Dr. Ambros and Dr. Ruvkun led the groups that identified the first microRNA and the first microRNA target. Dr. Ambros' lab yielded the discovery of the first microRNA and Dr. Ruvkun's lab identified how that microRNA regulates its target messenger. Working together, they demonstrated that the microRNA inactivates its target through direct, base-pairing interactions. MicroRNAs have been linked to cancer and identified as regulators of numerous other developmental events in both plants and animals. As a result of this discovery, researchers are now exploring microRNAs for use in diagnosis and prognosis as well as potential therapies.

"We are honored to join the distinguished list of past awardees of the Dr. Paul Janssen Award for Biomedical Research," said Ambros, the Silverman Chair in Natural Sciences and professor in the Program in Molecular Medicine at UMass Medical School in Worcester, MA. "It is a testament to the wisdom of private and government patrons that fundamental research such as ours was supported over the years, and that it is paying off in new understanding of disease processesand possibly in cures for patients."

"Our research grew out of long-standing traditions in the field aiming to unearth molecular explanations for how bi
'/>"/>

Contact: Jim Fessenden
james.fessenden@umassmed.edu
508-856-2000
University of Massachusetts Medical School
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related medicine news :

1. Researchers reveal crucial immune fighter role of the STING protein
2. MDS researchers join forces to advance patient treatments and outcomes
3. Childhood obesity linked to math performance, MU researcher says
4. Stanford researchers discover the African cichlids noisy courtship ritual
5. Researchers determine pathway for origin of most common form of brain and spinal cord tumor
6. Moffitt researcher, colleagues find success with new immune approach to fighting some cancers
7. Children with asthma marginalized in movies, says Rutgers-Camden researcher
8. UCI researchers create mosquitoes incapable of transmitting malaria
9. Moffitt Cancer Center researchers develop and test new anti-cancer vaccine
10. Penn and Cornell researchers spearhead the development of new guidelines for veterinary CPR
11. VCU researchers identify changes in cholesterol metabolic pathways

Post Your Comments:

(Date:5/19/2013)... (PRWEB) May 19, 2013 Healthcare leaders ... 19-22, 2013, at the Walt Disney World Swan and ... in supply chain innovation, care delivery and healthcare reform ... dynamic in all healthcare markets, with consolidation, ... the conversation,” said Todd Ebert, Amerinet president and CEO. ...

(Date:5/19/2013)... May 19, 2013 The muscles in ... their functionality and one of the biggest and most ... nervous system. The peripheral system comprises of peripheral nerves ... cord. These nerves ensure that the limbs and hands, ... when these nerves get damaged due to trauma or ...

(Date:5/19/2013)... TX (PRWEB) May 19, 2013 ... analysis for US, UK, Spain, Japan, Italy, Germany ... to the molecular diagnostics laboratory practice, as well ... trends with significant market impact during the next ... DNA probe and biochip technologies, test formats, detection ...

(Date:5/19/2013)... Colorado (PRWEB) May 19, 2013 Farming ... first seed in the ground 10,000 years ago. Most ... increased farm productivity by using genetically engineered seeds and ... now seeing a backlash to these techniques due to ... and chemicals and a corresponding surge in interest in ...

(Date:5/19/2013)... (PRWEB) May 19, 2013 Agora Health Limited ... that covers guides on how to increase memory power ... memory training method that helps people re-new their entire health ... and beat depression caused by a fatigued mind. In addition, ... razor sharp for a lifetime. The author claimed that this ...

Breaking Medicine News(10 mins):Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2 Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2 Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2 Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3 Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4 Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2 Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3 Health News:How To Increase Memory Power | How “Agora Health Limited” Helps People Improve Their Memory Naturally And Effectively – Health Review 2

[0] Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery [0] Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy [0] Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com [0] Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics [0] How To Increase Memory Power | How “Agora Health Limited” Helps People Improve Their Memory Naturally And Effectively – Health Review

... Revenue increases 7 percent to $23 billion -- Diluted earnings per ... EPS from continuing operations ... $0.90 per share -- Full year Non-GAAP ... -- Renews three-year, multi-billon-dollar Walgreens contract, DUBLIN, Ohio, Jan. 29 ...

... 29 , ... -- Net Sales of $1.07 billion represents an increase of 15% reported ... (10% constant currency), -- Diluted EPS were $1.12 reported, ... $1.18 adjusted, an increase of 16% over the prior year ...

... from American College of Surgeons helps patients do the,research ... 29 In today,s information-rich,environment, American consumers are stepping ... more prepared than ever. But according to results of ... consumer survey,when it comes to needing an operation, patients ...

... 29 The American Academy,of Family Physicians is pleased ... interest in improving access to health care. In doing,so, ... system reform., Improving Americans, ability to pay for ... health system that provides care to all, ensures the,financial ...

... Bill Novelli,made the following statement today in response ... (Logo: http://www.newscom.com/cgi-bin/prnh/20070209/NYF043LOGO ), "We hope ... beyond,rhetoric and towards bipartisan solutions that are fair ... together, openly,debate all available options, and solve our ...

... CEO Bill Novelli,made the following statement about today,s ... (Nunez & Perata) by the California State Senate,Committee ... failed to seize an opportunity to,fix their broken ... the,status quo - which includes millions of uninsured ...

Cardinal Health Reports Second Quarter Results, Revises EPS Outlook Zimmer Reports Fourth Quarter and 2007 Financial Results Survey Says: Patients Prep Harder for Vacation than for an Operation AAFP Statement - Family Physicians to President Bush: Call for Improved Health Access is Only One Step to Comprehensive Reform Statement by AARP CEO Bill Novelli on President Bush's State of the Union AARP Disappointed in Senate's Inability to Pass Health Care Reform

(Date:5/16/2013)... NORTH CHICAGO, Ill. and MECHELEN, ... NV (Euronext: GLPG) and AbbVie (NYSE: ABBV ... development collaboration to include Crohn,s disease. Galapagos will fund ... which is designed to facilitate rapid progression into Phase ... Q2 2015, AbbVie will pay Galapagos $50 million. The ...

(Date:5/16/2013)... 2013 Today, the National Patient Advocate Foundation acknowledges ... of Representatives recently approved a bill that would prohibit ... higher out-of-pocket fees for newer, more expensive oral anti-cancer ... more severe side-effects. However, the bill was amended to ... continue to be a barrier to patients with cancer ...

(Date:5/16/2013)... , May 16, 2013 Amgen (NASDAQ: AMGN ... on Tuesday, May 21, 2013, at the Sheraton New York ... beginning at 10:00 a.m. Eastern Daylight Time. Joseph ... Research and Development at Amgen, will present at the conference. ... Events Calendar on Amgen,s website, www.amgen.com , under Investors. ...

Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6 National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2 National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3

[0] AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease [0] National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill [0] Amgen To Present At The UBS Global Life Sciences Conference

... 2011 Healthpoint today announced the launch of a ... Biotherapeutics, along with an updated brandmark and corporate tagline, ... is designed to communicate the company,s commitment to scientific ... contribute to improved outcomes and quality of life for ...

... Md., Feb. 23, 2011 The Cystic Fibrosis Foundation and ... development that targets the defective protein that causes cystic fibrosis, ... The trial was designed to evaluate patients age ... a CF mutation called G551D. The study included 161 patients ...

Cached Medicine Technology:Healthpoint Launches New Corporate Identity 2 Healthpoint Launches New Corporate Identity 3 Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 2 Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 3

Healthpoint Launches New Corporate Identity Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation

... CCR Medical's Articulating Tip ... units in the Industry. The ... intubation by providing an improved ... Conventional and Fiber Optic styles. ...

German Style MacIntosh Fiber Optic Blade Laryngoscopes...

CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....

Medicine Products:

Fiber Optic Articulating Tip Laryngoscope Handles German Style MacIntosh Fiber Optic Blade Laryngoscopes Phillips American Profile Fiberoptic Laryngoscopes Wis-Hipple/Wisconsin American Profile Fiberoptic Laryngoscopes